X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs TORRENT PHARMA - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA TORRENT PHARMA SANOFI INDIA/
TORRENT PHARMA
 
P/E (TTM) x 30.7 26.6 115.6% View Chart
P/BV x 5.4 6.5 83.3% View Chart
Dividend Yield % 1.7 3.1 54.2%  

Financials

 SANOFI INDIA   TORRENT PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
TORRENT PHARMA
Mar-16
SANOFI INDIA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs4,5601,720 265.1%   
Low Rs4,4001,134 388.2%   
Sales per share (Unadj.) Rs1,028.5394.5 260.7%  
Earnings per share (Unadj.) Rs129.0101.8 126.7%  
Cash flow per share (Unadj.) Rs186.0116.3 159.9%  
Dividends per share (Unadj.) Rs68.0040.00 170.0%  
Dividend yield (eoy) %1.52.8 54.1%  
Book value per share (Unadj.) Rs753.6200.3 376.3%  
Shares outstanding (eoy) m23.03169.22 13.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.43.6 120.5%   
Avg P/E ratio x34.714.0 247.8%  
P/CF ratio (eoy) x24.112.3 196.4%  
Price / Book Value ratio x5.97.1 83.4%  
Dividend payout %52.739.3 134.2%   
Avg Mkt Cap Rs m103,174241,435 42.7%   
No. of employees `0003.610.9 33.3%   
Total wages/salary Rs m3,5928,559 42.0%   
Avg. sales/employee Rs Th6,537.76,129.6 106.7%   
Avg. wages/employee Rs Th991.4785.8 126.2%   
Avg. net profit/employee Rs Th819.81,581.3 51.8%   
INCOME DATA
Net Sales Rs m23,68666,764 35.5%  
Other income Rs m7082,156 32.8%   
Total revenues Rs m24,39468,920 35.4%   
Gross profit Rs m5,28127,204 19.4%  
Depreciation Rs m1,3132,461 53.4%   
Interest Rs m151,859 0.8%   
Profit before tax Rs m4,66125,041 18.6%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-1,403 0.0%   
Tax Rs m1,6916,414 26.4%   
Profit after tax Rs m2,97017,224 17.2%  
Gross profit margin %22.340.7 54.7%  
Effective tax rate %36.325.6 141.6%   
Net profit margin %12.525.8 48.6%  
BALANCE SHEET DATA
Current assets Rs m15,67346,622 33.6%   
Current liabilities Rs m6,67832,843 20.3%   
Net working cap to sales %38.020.6 184.0%  
Current ratio x2.31.4 165.3%  
Inventory Days Days7674 102.4%  
Debtors Days Days2279 28.2%  
Net fixed assets Rs m8,09839,029 20.7%   
Share capital Rs m230846 27.2%   
"Free" reserves Rs m17,08831,400 54.4%   
Net worth Rs m17,35633,890 51.2%   
Long term debt Rs m018,637 0.0%   
Total assets Rs m25,40090,136 28.2%  
Interest coverage x311.714.5 2,154.0%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.90.7 125.9%   
Return on assets %11.821.2 55.5%  
Return on equity %17.150.8 33.7%  
Return on capital %26.948.5 55.5%  
Exports to sales %24.543.3 56.5%   
Imports to sales %28.06.9 407.5%   
Exports (fob) Rs m5,80128,934 20.0%   
Imports (cif) Rs m6,6274,584 144.6%   
Fx inflow Rs m7,14529,185 24.5%   
Fx outflow Rs m6,8466,021 113.7%   
Net fx Rs m29923,165 1.3%   
CASH FLOW
From Operations Rs m3,22627,132 11.9%  
From Investments Rs m-1,555-7,014 22.2%  
From Financial Activity Rs m-1,818-14,352 12.7%  
Net Cashflow Rs m-1475,767 -2.5%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 7.0 205.1%  
FIIs % 14.6 12.6 115.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 8.8 119.3%  
Shareholders   15,184 26,511 57.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   ELDER PHARMA  FDC LTD.  SUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Global Markets Amid Fed and ECB Minutes, L&T, Power Grid & IOC Among Other Top Stocks to Watch Out Today(Pre-Open)

On Thursday, Indian share markets oscillated between green and red in a broad range throughout the day and ended the session with marginal gains, with Nifty holding 9,900 mark.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Aug 17, 2017 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS